PO-44 - Tissue factor pathway inhibitor-2 (TFPI-2) is cleaved by PRSS3: implication for tumor endothelial cells migration.

Ghilardi, C; Anastasia, A; Avigni, R; Lupi, M; Giavazzi, R; Bani, M R

Ghilardi, C; Anastasia, A; Avigni, R; Lupi, M; Giavazzi, R; Bani, M R.

Afiliación

Ghilardi C; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Dept. of Oncology, Milan, Italy.
Anastasia A; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Dept. of Oncology, Milan, Italy.
Avigni R; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Dept. of Oncology, Milan, Italy.
Lupi M; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Dept. of Oncology, Milan, Italy.
Giavazzi R; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Dept. of Oncology, Milan, Italy.
Bani MR; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Dept. of Oncology, Milan, Italy.

Thromb Res ; 140 Suppl 1: S192-3, 2016 Apr.

Article en En | MEDLINE | ID: mdl-27161730

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Thromb Res Año: 2016 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google